Kyverna Therapeutics
KYTX
#8475
Rank
A$0.40 B
Marketcap
A$6.44
Share price
-2.52%
Change (1 day)
-41.37%
Change (1 year)

Kyverna Therapeutics (KYTX) - Total debt

Total debt on the balance sheet as of June 2026 : A$49.85 Million

According to Kyverna Therapeutics's latest financial reports the company's total debt is A$49.85 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Kyverna Therapeutics - Total debt on balance sheet (from 2022 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$43.34 M227.11%
2024-12-31A$13.25 M-0.56%
2023-12-31A$13.32 M-14.16%
2022-12-31A$15.52 M102.6%
2021-12-31A$7.66 M